Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 76, 2021 - Issue 6
4,479
Views
10
CrossRef citations to date
0
Altmetric
Articles

Biosimilars in Belgium: a proposal for a more competitive market

ORCID Icon, ORCID Icon & ORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Steven Simoens & Arnold G. Vulto. (2021) A health economic guide to market access of biosimilars. Expert Opinion on Biological Therapy 21:1, pages 9-17.
Read now

Articles from other publishers (9)

Evelien Moorkens, Teresa Barcina Lacosta, Dalia Dawoud, András Inotai, Manthan Janodia, Chia Jie Tan, Ka Keat Lim, Nishtha Khatri, Catarina Lopes Pereira & Steven Simoens. (2023) A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report. Value in Health 26:8, pages 1137-1144.
Crossref
Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Zilke Claessens, Thomas Desmet, Evelien De Sutter, Laurenz Govaerts, Rosanne Janssens, Teodora Lalova, Evelien Moorkens, Robbe Saesen, Elise Schoefs, Yannick Vandenplas, Eline Van Overbeeke, Ciska Verbaanderd & Isabelle Huys. (2022) How to balance valuable innovation with affordable access to medicines in Belgium?. Frontiers in Pharmacology 13.
Crossref
Liese Barbier, Steven Simoens, Paul Declerck, Arnold G. Vulto & Isabelle Huys. (2022) Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking. Frontiers in Pharmacology 13.
Crossref
Soon Cien Chong, Retha Rajah, Poh Lee Chow, Hsio Ching Tan, Chin Man Chong, Kar Yee Khor, Wan Ping Lee & Wan Ying Tan. (2022) Perspectives toward biosimilars among oncologists: A Malaysian survey. Journal of Oncology Pharmacy Practice, pages 107815522211047.
Crossref
Yannick Vandenplas, Liese Barbier, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto & Isabelle Huys. (2022) Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care. Frontiers in Pharmacology 12.
Crossref
Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto & Isabelle Huys. (2021) Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians. Journal of Pharmaceutical Policy and Practice 14:1.
Crossref
Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto & Isabelle Huys. (2021) Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis. Frontiers in Pharmacology 12.
Crossref
Philippe Van Wilder. (2021) The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?. Pharmaceuticals 14:4, pages 352.
Crossref
Evelien Moorkens, Arnold G. Vulto, James Kent, Lindsay McClure, Richard Boldero, Thibault Vanhove, Steven Simoens & Isabelle Huys. (2020) A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study. BioDrugs 35:1, pages 75-87.
Crossref